Department of Pediatrics, Division of Cardiology, Lucile Packard Children's Hospital at Stanford Medical Center, Stanford, CA.
Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA.
Pediatr Crit Care Med. 2022 Nov 1;23(11):860-871. doi: 10.1097/PCC.0000000000003040. Epub 2022 Jul 27.
IV calcium administration during cardiopulmonary resuscitation (CPR) for pediatric in-hospital cardiac arrest (IHCA) is associated with worse survival. We evaluated survival to hospital discharge in children with heart disease (HD), where calcium is more frequently administered during CPR.
Retrospective study of a multicenter registry database.
Data reported to the American Heart Association's (AHA) Get With The Guidelines-Resuscitation registry.
Children younger than 18 years with HD experiencing an index IHCA event requiring CPR between January 2000 and January 2019. Using propensity score matching (PSM), we selected matched cohorts of children receiving and not receiving IV calcium during CPR and compared the primary outcome of survival to hospital discharge.
None.
We included 4,556 children with HD experiencing IHCA. Calcium was administered in 1,986 (44%), more frequently in children younger than 1 year old (65% vs 35%; p < 0.001) and surgical cardiac (SC) compared with medical cardiac patients (51% vs 36%; p < 0.001). Calcium administration during CPR was associated with longer duration CPR (median 27 min [interquartile range (IQR): 10-50 min] vs 5 min [IQR, 2-16 min]; p < 0.001) and more frequent extracorporeal-CPR deployment (25% vs 8%; p < 0.001). In the PSM cohort, those receiving calcium had decreased survival to hospital discharge (39% vs 46%; p = 0.02) compared with those not receiving calcium. In a subgroup analysis, decreased discharge survival was only seen in SC cohorts.
Calcium administration during CPR for children with HD experiencing IHCA is common and is associated with worse survival. Administration of calcium during CPR in children with HD should be restricted to specific indications as recommended by the AHA CPR guidelines.
心肺复苏(CPR)期间静脉补钙与儿科院内心搏骤停(IHCA)后存活率降低相关。我们评估了心脏病(HD)患儿 CPR 期间更常补钙时的出院存活率。
多中心注册数据库的回顾性研究。
美国心脏协会(AHA)Get With The Guidelines-Resuscitation 注册数据库报告的数据。
2000 年 1 月至 2019 年 1 月期间发生需要 CPR 的 IHCA 事件的年龄<18 岁的 HD 患儿。使用倾向评分匹配(PSM),我们选择了接受和未接受 CPR 时静脉补钙的匹配队列,并比较了主要结局即出院存活率。
无。
我们纳入了 4556 例发生 IHCA 的 HD 患儿。1986 例(44%)患儿接受了钙治疗,1 岁以下患儿(65%比 35%;p<0.001)和心脏手术(SC)患儿(51%比 36%;p<0.001)更常接受钙治疗。CPR 期间给予钙与更长的 CPR 时间(中位数 27 min [四分位距:10-50 min]比 5 min [IQR,2-16 min];p<0.001)和更频繁的体外心肺复苏(ECPR)应用(25%比 8%;p<0.001)相关。在 PSM 队列中,接受钙治疗的患儿出院存活率(39%比 46%;p=0.02)较未接受钙治疗的患儿低。在亚组分析中,仅在 SC 队列中观察到出院存活率降低。
HD 患儿 IHCA 时 CPR 期间给予钙是常见的,且与存活率降低相关。HD 患儿 CPR 时应根据 AHA CPR 指南推荐的特定适应证限制钙的应用。